HUYA Bioscience Announces Agreement To Provide Schering- Plough With Drug Development Candidates From China

Collaboration will leverage HUYA’s growing Chinese bioscience network

San Diego, CA, USA – December 15, 2008 — HUYA Bioscience International, a leader in US/China pharmaceutical co-development, today announced an agreement with Schering-Plough Corporation’s subsidiary, N.V. Organon. Schering-Plough has selected HUYA to identify and present to Schering-Plough on an exclusive basis proprietary lead, preclinical and clinical drug candidates in specific therapeutic areas that originate in China. Read more